Patients with autoimmune lymphoproliferative syndrome (ALPS) have defective lymphocyte apoptosis, with increased risk for lymphoid malignancies. Herein, we report a patient with ALPS who developed histiocytic sarcoma in a background of sinus histiocytosis and massive lymphadenopathy (SHML) or Rosai-Dorfman disease (RDD). This patient had documented ALPS type Ia with a germline missense mutation in exon 9 of the TNFRSF6 gene (973 A>T, D244V) encoding Fas (CD95/Apo-1). He presented at 10 months with hepatosplenomegaly and autoimmune hemolytic anemia and was diagnosed with ALPS. At age 6 and½, he developed classical Hodgkin lymphoma, which was treated using standard chemotherapy. Two years later, biopsy of a PETpositive axillary node showed features of ALPS and focal involvement by SHML. Thereafter, the patient continued to have continued lymphadenopathy and progressive splenomegaly, leading to exploratory surgery at age 13 for suspicion of lymphoma. Paraabdominal nodes revealed sheets of malignant-looking histiocytes with increased mitotic activity and areas of necrosis, indicative of histiocytic sarcoma. Spleen and lymph nodes also showed involvement by RDD. Both components had an identical phenotype of S-100+/CD68+/CD163+. The occurrence of malignancies involving two separate hematopoietic lineages in ALPS is not previously reported. Given the central role of defective Fas signaling in ALPS, histiocytes may be yet another lineage at risk for neoplastic transformation secondary to a block in apoptosis.Keywords histiocytic sarcoma; Rosai-Dorfman disease; sinus histiocytosis with massive lymphadenopathy; apoptosis; autoimmune lymphoproliferative syndrome Correspondence and reprint requests: Elaine S. Jaffe, M.D., National Cancer Institute, 10, Center Drive, Building 10, Room 2B 42, Bethesda, MD 20892, elainejaffe@nih.gov. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author ManuscriptAm J Surg Pathol. Author manuscript; available in PMC 2011 April 1. Benign histiocytic proliferations have been described previously by our group,13 as well others, 15 in the context of ALPS, although these generally do not attain clinical significance. We previously characterized the occurrence of SHML-type S-100 positive histiocytes reminiscent of Rosai-Dorfman disease (RDD) in a cohort of 44 patients with ALPS Type Ia. 13 RDD changes were more commonly found in patients with severe symptomatology, and were more common in males than females. Clinical manifestations of the RDD were generally self-limited, without progression noted.
CASE REPORTA 13 year old boy presen...